1vgn
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Structure-based design of the irreversible inhibitors to metallo--lactamase (IMP-1)== | ==Structure-based design of the irreversible inhibitors to metallo--lactamase (IMP-1)== | ||
| - | <StructureSection load='1vgn' size='340' side='right' caption='[[1vgn]], [[Resolution|resolution]] 2.63Å' scene=''> | + | <StructureSection load='1vgn' size='340' side='right'caption='[[1vgn]], [[Resolution|resolution]] 2.63Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1vgn]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_marcescens"_(bizio_1823)_trevisan_in_de_toni_and_trevisan_1889 "bacillus marcescens" (bizio 1823) trevisan in de toni and trevisan 1889]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VGN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1VGN FirstGlance]. <br> | <table><tr><td colspan='2'>[[1vgn]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_marcescens"_(bizio_1823)_trevisan_in_de_toni_and_trevisan_1889 "bacillus marcescens" (bizio 1823) trevisan in de toni and trevisan 1889]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VGN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1VGN FirstGlance]. <br> | ||
| Line 22: | Line 22: | ||
==See Also== | ==See Also== | ||
| - | *[[Beta-lactamase|Beta-lactamase]] | + | *[[Beta-lactamase 3D structures|Beta-lactamase 3D structures]] |
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Beta-lactamase]] | [[Category: Beta-lactamase]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Arakawa, Y]] | [[Category: Arakawa, Y]] | ||
[[Category: Goto, M]] | [[Category: Goto, M]] | ||
Revision as of 10:42, 8 January 2020
Structure-based design of the irreversible inhibitors to metallo--lactamase (IMP-1)
| |||||||||||
